ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Cohance Lifesciences clarified that no pending information exists regarding the recent increase in trading volume. The company remains compliant with SEBI regulations.
Cohance Lifesciences Limited clarified that there is no undisclosed information or event causing the recent share price movement. The company confirmed it remains compliant with SEBI disclosure regulations, having previously intimated the outcome of its April 27, 2026, board meeting.
Cohance Lifesciences Limited clarified that recent increases in share trading volume are purely market-driven. The company confirmed there is no undisclosed price-sensitive information or pending announcements that could impact trading behaviour. All regulatory disclosures under SEBI Listing Regulations remain up to date.
Cohance Lifesciences Limited clarified that the recent increase in share trading volume is purely market-driven and attributable to prevailing conditions. The company confirmed there is no pending undisclosed price-sensitive information. All regulatory disclosures under SEBI Listing Regulations are up to date, ensuring transparency for investors regarding the scrip's behavior.